Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by HighteawithIntrepidon May 10, 2018 5:00pm
218 Views
Post# 28014612

RE:Dear real PLI longs

RE:Dear real PLI longs At the moment PL has sold us out to Thomvest. We have custody of
our intellectual property but they own it unless the stars align and we are
able to pay them back. Great science but for anyone with a serious understanding 
of accounting or that has spent a lot of time drinking beer with the RCMP bankruptcy guys 
if it looks like a duck and quacks like a duck chances are it’s a duck.
Own it as a long shot lottery ticket not a substitute for Pfizer. Conscripts believe 
PL understated the time lines and really didn’t understand the FDA’s needs. A definite FUBAR.
We have great science but without cash on the balance sheet we are going cap in 
hand to future partners. The only person PL cares about is himself and then our future patients.
Still view this as a lottery ticket not a major part of the portfolio but definitely the most interesting.
 Keep your stick on the ice. HT
Bullboard Posts